Global Topical Drug Delivery Market

 

Topical drug delivery is defined as the delivery of drugs through topical route like skin, mucus membrane or cavities in the body. These are applied topically the body. These drugs are applied locally to avoid the first-pass effect of the drug or for site-specific action. These medications include foams, lotions, creams, gels, ointments, and others. Topical drug delivery has various benefits such as site-specificity, better compliance, eliminating fluctuations in the levels of drugs, and improved suitability for self-medication.

 

Market Drivers

 

The increase in approval of new drugs from U.S. FDA is expected to drive growth of the global topical drug delivery market. For instance, in August 2020, the U.S. Food and Drug Administration (FDA) announced the approval of Cassiopea’s Winlevi drug, which is used for the treatment of topical acne treatment from. Furthermore, the increase in prevalence of skin diseases and high incidence of burn injuries, expected to boost the global topical drug delivery market growth over the forecast period. For instance, Information provided by the World Health Organization (WHO), around 2 to 3 million cases of non-melanoma skin cancer and around 132,000 cases of melanoma skin cancer are diagnosed every year across the globe.

 

Moreover, new product launches are expected to boost the global topical drug delivery market. For instance, in February 2021, Almirall U.S., biopharmaceutical company focused on skin health, launched new drug (Klisyri). It is used as the topical treatment for actinic keratosis (AK) of the face and scalp. Actinic keratosis (AK) is the most common diagnosis made by dermatologists in the United States, affects more than 40 million Americans annually. In addition, the increase in geriatric population will positively influence the global topical drug delivery market growth throughout the forecast period.

 

Market Restraints

 

Availability of alternative dug delivery modes for patients and end users expected to hamper the global topical drug delivery market growth. Also, side effects of topical drugs like allergies and rashes, and slow onset of action hinder the growth of global topical drug delivery market growth.

 

Market Segmentation

 

On the basis of product type global topical drug delivery system market is segmented into Formulations, and devices. Further, formulations are sub segmented into Semisolid (Creams, Gels, Pastes, Ointments, and Lotions), Liquid (Solutions, Suspensions), and Solid (Suppositories, and Powders). Also, the Devices are classified into Transdermal Patches, and Transdermal Gels.

 

 Based on the product type semisolid is expected to witness the highest growth throughout the forecast period. Due to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance.

 

Based on the route of administration market is segmented into Skin, Ophthalmic, Rectal, Vaginal, and Nasal. In addition, the market is segmented into end user such as Home Care Settings, Hospitals & Private Clinics, and Others. The home care settings segment holds largest share of the market during this forecast period, owing to factors such as the convenience & affordability of topical drugs for home administration.

 

Regional Analysis

 

The Global Topical Drug Delivery Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

 

The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. This is due to the increase of skin diseases like skin cancer, the growing use of contraceptives, and the increase in focus of pharmaceutical companies on the research and development of smart transdermal drug delivery systems, all of which are propelling adoption of topical drug delivery in the region. Also, the North America dominates the market due to the presence of large number of pharmaceutical companies & drug delivery technology providers in the region.

 

Key Players

 

Some key operating players are listed in this report such as Bausch Health Companies, Agile Therapeutics, Hisamitsu Pharmaceutical, Cipla, Almirall U.S., Cassiopea, Crescita Therapeutics Inc., 3M, MERCK & CO., Bayer AG, etc. Merger acquisition, partnership, and product launch are some key strategies adopted by the key players & sustain and capture the market share in the global topical drug delivery market. For instance, in December 2020, Agile Therapeutics, Inc. had launched its new Twirla (levonorgestrel and ethinyl estradiol) transdermal system which is a contraceptive patch.

 

Market Taxonomy

By Product type

 

  • Formulations
  • Semisolid
  • Creams
  • Gels
  • Pastes
  • Ointments
  • Lotions
  •  Liquid
  • Solutions
  • Suspensions
  • Solid
  • Suppositories
  • Powders
  • Devices
  • Transdermal Patches
  • Transdermal Gels

 

By Route of Administration

  • Skin
  • Ophthalmic
  • Rectal
  • Vaginal
  •  Nasal

 

By End User

  • Home Care Settings
  •  Hospitals & Private Clinics
  •  Others

 

Key Questions Addressed by the Report

  • What are the Key Opportunities in Global Topical Drug Delivery Market?
  • What will be the growth rate from 2019 to 2030?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

 

Global Topical Drug Delivery Market

 

1 Introduction        
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope

 

2 Research Methodology

2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

 

3 Executive Summary


4 Global Topical Drug Delivery Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

 

5 Global Topical Drug Delivery Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type

5.2 Global Topical Drug Delivery Market Share Analysis, By Product Type

5.3 Global Topical Drug Delivery Market Size and Forecast, By Product Type
5.3.1Formulations

5.3.1.1 semisolid (Creams, Gels, Pastes, Ointments, and Lotions)

5.3.1.2. Liquid (Solutions, Suspensions)

5.3.1.3. Solid (Suppositories, and Powders)

5.3.2. Devices

5.3.2.1 Transdermal Patches

5.3.2.2. Transdermal Gels

 

6 Global Topical Drug Delivery Market, By Route of Administration
6.1 Y-o-Y Growth Comparison, By Route of Administration

6.2 Global Topical Drug Delivery Market Share Analysis, By Route of Administration

6.3 Global Topical Drug Delivery Market Size and Forecast, By Route of Administration
6.3.1 Skin

6.3.2 Ophthalmic

6.3.3 Rectal

6.3.4 Vaginal

6.3.5. Nasal

 

7 Global Topical Drug Delivery Market, By End User
7.1 Y-o-Y Growth Comparison, By End User

7.2 Global Topical Drug Delivery Market Share Analysis, By End User

7.3 Global Topical Drug Delivery Market Size and Forecast, By End User
7.3. 1Home Care Settings

7.3.2. Hospitals & Private Clinics

7.3.3. Others

 

8Global Topical Drug Delivery Market, By Region
8.1 Global Topical Drug Delivery Market Share Analysis, By Region

8.2 Global Topical Drug Delivery Market Share Analysis, By Region

8.3 Global Topical Drug Delivery Market Size and Forecast, By Region

 

9 North America Topical Drug Delivery Market Analysis and Forecast (2020-2030)
9.1 Introduction

9.2 North America Topical Drug Delivery Market Share Analysis, By Product Type

9.3 North America Topical Drug Delivery Market Size and Forecast, By Route of Administration

9.4 North America Topical Drug Delivery Market Size and Forecast, By End User

9.5 North America Topical Drug Delivery Market Size and Forecast, By Country

9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico

 

10EuropeTopical Drug Delivery Market Analysis and Forecast (2020-2030)
10.1 Introduction

10.2 Europe Topical Drug Delivery Market Share Analysis, By Product Type

10.3 Europe Topical Drug Delivery Market Size and Forecast, By Route of Administration

10.4 Europe Topical Drug Delivery Market Size and Forecast, By End User

10.5 Europe Topical Drug Delivery Market Size and Forecast, By Country

10.5.1 Germany
10.5.2 France
10.5.3 UK

10.54. Rest of Europe

 

11Asia Pacific Topical Drug Delivery Market Analysis and Forecast (2020-2030)
11.1 Introduction

11.2 Asia Pacific Topical Drug Delivery Market Share Analysis, By Product Type

11.3 Asia Pacific Topical Drug Delivery Market Size and Forecast, By Route of Administration

11.4 Asia Pacific Topical Drug Delivery Market Size and Forecast, By End User

11.5 Asia Pacific Topical Drug Delivery Market Size and Forecast, By Country

11.5.1 China
11.5.2 Japan
11.5.3 India

11.5.4. Rest of Asia Pacific

 

12Latin America Topical Drug Delivery Market Analysis and Forecast (2020-2030)
12.1 Introduction

12.2 Latin America Topical Drug Delivery Market Share Analysis, By Product Type

12.3 Latin America Topical Drug Delivery Market Size and Forecast, By Route of Administration

12.4 Latin America Topical Drug Delivery Market Size and Forecast, By End User

12.5 Latin America Topical Drug Delivery Market Size and Forecast, Country

 

13Middle East Topical Drug Delivery Market Analysis and Forecast (2020-2030)
13.1 Introduction

 13.2 Middle East Topical Drug Delivery Market Share Analysis, By Product Type

13.3 Middle East Topical Drug Delivery Market Size and Forecast, By Route of Administration

13.4 Middle East Topical Drug Delivery Market Size and Forecast, By End User

13.5 Middle East Topical Drug Delivery Market Size and Forecast, By Country

 

14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies

 

15Company Profiles

 

15.1 Bausch Health Companies

15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview

15.1.5 Key Market Developments

15.1.6 Key Strategies

 

15.2. Agile Therapeutics

15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview

15.2.5 Key Market Developments

15.2.6 Key Strategies

 

15.3. Hisamitsu Pharmaceutical

15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview

15.3.5 Key Market Developments

15.3.6 Key Strategies

 

15.4 Cipla

15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview

15.4.5 Key Market Developments

15.4.6 Key Strategies

 

15.5 Almirall U.S.

15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview

15.5.5 Key Market Developments

15.5.6 Key Strategies

 

15.6 Cassiopea
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview

15.6.5 Key Market Developments

15.6.6 Key Strategies

 

15.7 Crescita Therapeutics Inc

15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview

15.7.5 Key Market Developments

15.7.6 Key Strategies        

 

15.8 3M

15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview

15.8.5 Key Market Developments

15.8.6 Key Strategies

 

15.9 MERCK & CO

15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview

15.9.5 Key Market Developments

15.9.6 Key Strategies

 

15.10 Bayer AG

15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview

15.10.5 Key Market Developments

15.10.6 Key Strategies